INC Research announced a two-year partnership with the Society for Clinical Research Sites.
INC Research, a global Phase I to IV clinical research organization (CRO), announced a two-year partnership with the Society for Clinical Research Sites (SCRS), a global trade organization fully dedicated to representing the interests of clinical research sites. INC will participate as a Global Impact Partner (GIP), the highest level of membership within SCRS. GIPs participate on the SCRS Global Impact Board at an executive level. Working in tandem with SCRS’ Leadership Council, the Board helps set strategic initiatives for the Society, which advocates, connects, educates, and mentors more than 1,400 sites represented across 22 countries.
Read the full release here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.